ARTICLE | Company News
Harvard University endocrine, metabolic, cardiovascular news
December 3, 2007 8:00 AM UTC
The university spun out Syndexa Pharmaceuticals Corp. to develop compounds that target molecular mechanisms linking chronic inflammation to metabolic and other diseases, including Type II diabetes an...